Business of Optometry News

LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this Healio Video Perspective from SightLine.

Union membership among health care professionals in the United States, including physicians, is on the rise, which could have seismic implications in work patterns and patient care in an increasingly corporatized medical system.

The recent increase in tariffs on Chinese imports has resulted in tariffs as high as 178% on some optical products, which could significantly affect the cost of eyeglasses and other products, according to a Vision Council press release.

The FDA cleared Luminopia, a virtual reality-based therapeutic for amblyopia, for use in children aged 8 to 12 years old, adding to its existing approval in children aged 4 to 7 years old, according to a press release.

Health savings accounts are a powerful tool for managing health care expenses, offering significant tax advantages and flexibility.

  The FDA issued a complete response letter for a supplemental biologics license application, in which it did not approve extending the dosing intervals for Eylea HD, according to a press release from Regeneron.

  The FDA granted 510(k) clearance for Leos, a laser endoscopy ophthalmic system for a more intuitive laser endoscopic cyclophotocoagulation procedure, according to a press release from BVI Medical.

The FDA granted regenerative medicine advanced therapy designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

Things will be a little different ahead of this year’s American Society of Cataract and Refractive Surgery meeting in Los Angeles as ASCRS debuts SightLine, a new single-day meeting.

  Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, according to a press release.